Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Empowering Change: The Global Environmental Health and Energy Working Group at Duke University
00:10:00
Huang Baozhong - CABSAT 2015 - WTA Executive Dialogue Series | Mr. WANG Hongbin, CEO, APT Satellite Holdings Ltd1045:HKG
00:10:00
Unveiling the Unseen: Exploring Ground-Penetrating Radar in Art and Education
00:00:00
Dr. Dawn Jaroszewski, Mayo Clinic
00:10:00
Bradesco's Digital Evolution: Pioneering Tech Integration for Enhanced Customer Experience | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:10:00
John Wood, CEO of Telos, discusses the origins and benefits of the company's partnership with AWS Public Sector.
00:10:00
Invest in companies led by women people of color and LGBTQIA|Brittany Davis,General Partner,Backstage Capital
00:10:00
Minister Dele Alake Exclusive on TVC's Business Nigeria | Dele Alake - Minister Of Solid Minerals of Nigeria
00:10:00
First Circle Capital on seeding the next Fintech generation in Africa|Selma Ribica,Co-Founder & Managing Partner,First Circle
00:10:00
In the "Behind the Bell" series, Nelson Griggs, President of the Nasdaq Stock Exchange, and Josh James, CEO of Domo, Inc., discussed the intersection of technology and business growth, focusing on how innovative tech solutions are driving new opportunitie
00:10:00
From Humble Beginnings to Entrepreneurial Success: A Journey of Dreaming Big and Taking Risks| Robert Reffkin, CEO, Compass Inc.
00:00:00
Leslie F. Thomas, M.D. Nephrologist, Mayo Clinic

© 2017 - Neuhu+